Skip to main content
. Author manuscript; available in PMC: 2015 Feb 4.
Published in final edited form as: J Neurooncol. 2013 Nov 29;116(3):543–549. doi: 10.1007/s11060-013-1318-9

Fig. 1.

Fig. 1

ΔR2* time-series for each of the components averaged across patients for each dose. For the first dose (left), time-series are shown for the arterial, venous, and the leakage-affected third component. The time-series for the second dose shown include arterial, venous, and the average signal within a mask defined by the leakage-affected first dose component